retatrutide trial data Eli Lilly and Company's triple agonist, retatrutide, successful in two additional phase 3 obesity trials, delivering significant improvements in weight and A1C Retatrutide Contraindications: Risks and Considerations

Podobnik B, Demar L, arc L, Jerin A, Osredkar J, Trontelj J, Rokar R, Brvar M

This is a very serious side effect that can come on fast and strong, and result in serious personal injuries in an attempt or the wrongful death of an innocent person who succumbs to the pressures of this drug

That followed more than 40 similar letters in late 2025 and over 50 in September 2025

Q5: Can it be used long-term

5 Reasons Why GLP-1 Drugs like Ozempic and Wegovy May Not Help You Lose Weight

IV therapy, short for intravenous therapy, involves delivering vitamins, minerals, and other nutrients directly into your bloodstream through an IV drip